CJ Bioscience, Inc. (KOSDAQ:311690)
South Korea flag South Korea · Delayed Price · Currency is KRW
10,010
-90 (-0.89%)
At close: Apr 2, 2025, 3:30 PM KST

CJ Bioscience Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
130,785131,831147,076170,481286,048199,288
Upgrade
Market Cap Growth
-10.37%-10.37%-13.73%-40.40%43.54%39.15%
Upgrade
Enterprise Value
64,82798,118116,989139,502291,080185,214
Upgrade
Last Close Price
10010.0010090.0016140.0024887.5141793.8543939.33
Upgrade
PS Ratio
26.7838.0326.3841.8465.5637.52
Upgrade
PB Ratio
1.261.702.063.433.265.78
Upgrade
P/TBV Ratio
2.022.022.493.513.265.80
Upgrade
EV/Sales Ratio
18.7028.3020.9834.2466.7234.87
Upgrade
Debt / Equity Ratio
0.120.120.120.580.271.04
Upgrade
Asset Turnover
0.040.040.060.040.050.10
Upgrade
Inventory Turnover
22.2122.2132.5024.9010.6713.27
Upgrade
Quick Ratio
4.104.104.381.433.3913.19
Upgrade
Current Ratio
4.144.144.431.463.4213.68
Upgrade
Return on Equity (ROE)
-44.00%-44.00%-37.82%-50.78%-31.51%-26.82%
Upgrade
Return on Assets (ROA)
-22.44%-22.44%-21.95%-20.00%-6.66%-9.94%
Upgrade
Return on Capital (ROIC)
-25.61%-25.61%-25.26%-21.82%-6.94%-10.45%
Upgrade
Earnings Yield
-25.11%-24.91%-15.58%-20.48%-6.74%-4.40%
Upgrade
FCF Yield
-21.51%-21.34%-20.28%-14.73%-3.28%-10.03%
Upgrade
Buyback Yield / Dilution
-30.93%-30.93%-20.50%-38.23%-10.14%-16.93%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.